SAGE Therapeutics Inc (OQ:SAGE)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for SAGE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET November 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 12/19 Sep 11/19 Jonas Jeffrey M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -4,600  
Sep 12/19 Sep 11/19 Jonas Jeffrey M Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,600 $0.450
Sep 5/19 Sep 4/19 Kanes Stephen Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -6,000  
Sep 5/19 Sep 4/19 Kanes Stephen Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,000 $0.450
Aug 16/19 Aug 15/19 Frates James M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -8,000  
Aug 16/19 Aug 15/19 Frates James M Direct Ownership Common Stock S - Open market or private sale -8,000 $160.58
Aug 16/19 Aug 15/19 Frates James M Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,000 $28.35
Jul 29/19 Jul 25/19 Cloonan Michael Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,088 $161.38
Jul 29/19 Jul 25/19 Cloonan Michael Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,450  
Jul 29/19 Jul 25/19 Jonas Jeffrey M Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,685 $161.38
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for SAGE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET November 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 12/19 Sep 11/19 Jonas Jeffrey M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -4,600  
Sep 12/19 Sep 11/19 Jonas Jeffrey M Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,600 $0.450
Sep 5/19 Sep 4/19 Kanes Stephen Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -6,000  
Sep 5/19 Sep 4/19 Kanes Stephen Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,000 $0.450
Aug 16/19 Aug 15/19 Frates James M Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -8,000  
Aug 16/19 Aug 15/19 Frates James M Direct Ownership Common Stock S - Open market or private sale -8,000 $160.58
Aug 16/19 Aug 15/19 Frates James M Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,000 $28.35
Aug 16/19 May 6/19 Frates James M Direct Ownership Common Stock G - Gift -500  
Aug 16/19 May 6/19 Frates James M Direct Ownership Common Stock G - Gift -1,200  
Jul 29/19 Jul 25/19 Cloonan Michael Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,088 $161.38
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $SAGE

StockTwits